Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Marzia Menegatti"'
Autor:
Lone Hvitfeldt Poulsen, Bryce A. Kerlin, Giancarlo Castaman, Angelo Claudio Molinari, Marzia Menegatti, Diane Nugent, Sohan Dey, May‐Lill Garly, Manuel Carcao
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 2, Pp n/a-n/a (2022)
Abstract Background Regular factor XIII (FXIII) prophylaxis is standard treatment for congenital FXIII A‐subunit deficiency (FXIII‐A CD). Recombinant factor XIII‐A2 (rFXIII‐A2) was extensively evaluated in the mentor trials. Objective To asse
Externí odkaz:
https://doaj.org/article/5a6d8df7f0b441e8a7dd4b247b17f799
Autor:
Michel Guipponi, Frédéric Masclaux, Frédérique Sloan-Béna, Corinne Di Sanza, Namik Özbek, Flora Peyvandi, Marzia Menegatti, Alessandro Casini, Baris Malbora, Marguerite Neerman-Arbez
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Congenital afibrinogenemia is the most severe congenital fibrinogen disorder, characterized by undetectable fibrinogen in circulation. Causative mutations can be divided into two main classes: null mutations with no protein production at all and miss
Externí odkaz:
https://doaj.org/article/c125d7ef28a24e41a5ba6e9a79701f8e
Autor:
Elvezia Maria Paraboschi, Amit Vikram Khera, Piera Angelica Merlini, Laura Gigante, Flora Peyvandi, Mark Chaffin, Marzia Menegatti, Fabiana Busti, Domenico Girelli, Nicola Martinelli, Oliviero Olivieri, Sekar Kathiresan, Diego Ardissino, Rosanna Asselta, Stefano Duga
Publikováno v:
Haematologica, Vol 105, Iss 7 (2020)
Externí odkaz:
https://doaj.org/article/93e148b87d7744dbbcc14cb915ca2906
Autor:
Elvezia Maria Paraboschi, Marzia Menegatti, Valeria Rimoldi, Munira Borhany, Magy Abdelwahab, Donato Gemmati, Flora Peyvandi, Stefano Duga, Rosanna Asselta
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/b424ad316f0f4849aba5b7010e4f50f6
Autor:
Amy D. Shapiro, Marzia Menegatti, Roberta Palla, Marco Boscarino, Christopher Roberson, Paolo Lanzi, Joel Bowen, Charles Nakar, Isaac A. Janson, Flora Peyvandi
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
Plasminogen deficiency is an ultra-rare multisystem disorder characterized by the development of fibrin-rich pseudomembranes on mucous membranes. Ligneous conjunctivitis, which can result in vision impairment or loss, is the most frequent symptom rep
Externí odkaz:
https://doaj.org/article/8302c43f660645b99648d0e1b22824c7
Publikováno v:
Haematologica, Vol 93, Iss 6 (2008)
Factor X deficiency is a severe rare hemorrhagic condition inherited as an autosomal recessive trait. It is one of the most severe recessive inherited coagulation disorders. We analyzed the clinical manifestations, laboratory phenotype and genotype i
Externí odkaz:
https://doaj.org/article/a1026022fd9248e29cd78e13adc402e6
Autor:
Diane Nugent, Suchitra S. Acharya, Kimberly J. Baumann, Camille Bedrosian, Rebecca Bialas, Kai Brown, Deya Corzo, Amar Haidar, Catherine P. M. Hayward, Peter Marks, Marzia Menegatti, Margaret E. Miller, Kate Nammacher, Roberta Palla, Skye Peltier, Rajiv K. Pruthi, Michael Recht, Benny Sørensen, Michael Tarantino, Alisa S. Wolberg, Amy D. Shapiro
Publikováno v:
Expert Review of Hematology. 16:55-70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6486d5eba8d16bdacf24e5db6231a651
https://doi.org/10.1080/17474086.2023.2175661
https://doi.org/10.1080/17474086.2023.2175661
Autor:
Samin Mohsenian, Omid Seidizadeh, Roberta Palla, Mohammad Jazebi, Azita Azarkeivan, Somayeh Moazezi, Mohammad Reza Baghaipour, Marzia Menegatti, Flora Peyvandi
Publikováno v:
Haemophilia. 29:827-835
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1f83d0b7d4cc1291af71cf60bc6600d
https://doi.org/10.1111/hae.14773
https://doi.org/10.1111/hae.14773
Autor:
Lone Hvitfeldt Poulsen, Bryce A. Kerlin, Giancarlo Castaman, Angelo Claudio Molinari, Marzia Menegatti, Diane Nugent, Sohan Dey, May‐Lill Garly, Manuel Carcao
Publikováno v:
Poulsen, L H, Kerlin, B A, Castaman, G, Molinari, A C, Menegatti, M, Nugent, D, Dey, S, Garly, M L & Carcao, M 2022, ' Safety and effectiveness of recombinant factor XIII-A 2 in congenital factor XIII deficiency : Real-world evidence ', Research and Practice in Thrombosis and Haemostasis, vol. 6, no. 2, e12628 . https://doi.org/10.1002/rth2.12628
Background: Regular factor XIII (FXIII) prophylaxis is standard treatment for congenital FXIII A-subunit deficiency (FXIII-A CD). Recombinant factor XIII-A2 (rFXIII-A2) was extensively evaluated in the mentor trials. Objective: To assess real-world s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979b33524c63e439c706b7a765cdafcb
https://pure.au.dk/portal/da/publications/safety-and-effectiveness-of-recombinant-factor-xiiia2-in-congenital-factor-xiii-deficiency(6580b832-d3d2-40df-a1b5-c7122033fe24).html
https://pure.au.dk/portal/da/publications/safety-and-effectiveness-of-recombinant-factor-xiiia2-in-congenital-factor-xiii-deficiency(6580b832-d3d2-40df-a1b5-c7122033fe24).html
Publikováno v:
Hematology Am Soc Hematol Educ Program
Autoantibodies toward clotting factors may develop in people suffering from autoimmune or neoplastic diseases, after drug intake or even in subjects without apparent conditions. They are more commonly directed against factor VIII (FVIII) or von Wille
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85ce1ff5022af730a4deeed32b5b331
https://doi.org/10.1182/hematology.2019000066
https://doi.org/10.1182/hematology.2019000066